The Valley Desk

ArticleBiotechnology reports (Amsterdam, Netherlands)Published

Development and scale-up of rVSV-SARS-CoV-2 vaccine process using single use bioreactor

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name GSK, Merck & Co. Affiliation source

Institutions
GSK, Merck & Co.

Publication record

Type
Article
Venue
Biotechnology reports (Amsterdam, Netherlands)
Published
Subject terms
Vero cells; Microcarriers; Serum-free; Single Use Bioreactor; Closed Process; Vsv∆G-Sars-Cov-2
PubMed ID
36687766
PubMed Central ID
PMC9841742
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal